The Diagnostic and Clinical Significance of TFE3 Immunohistochemical Nuclear Expression in Solitary Fibrous Tumour

Figure 3

Histopathological and immunohistochemical features of SFT and other soft tumours as controls. H&E of SFT at (a) 100x and STAT6 positive expression of SFTat (b) 100x, H&E of malignant peripheral nerve sheath tumour at (c) 100x and positive Sox-10 expression in malignant peripheral nerve sheath tumour at (d) 100x, H&E staining of dermatofibrosarcoma protuberans at (e) 100x, and positive CD34 expression in dermatofibrosarcoma protuberans at (h) 100x. H&E staining of dedifferentiated liposarcoma at (g) 100x and positive MDM2 expression in dedifferentiated liposarcoma at (h) 100x.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)